BeOne Medicines (BEIGF) EBIT (2015 - 2026)
BeOne Medicines (BEIGF) reported EBIT of $249.9 million for Q1 2026, up 2150.96% year-over-year from $11.1 million in Q1 2025, and up 35.06% quarter-over-quarter from $185.0 million in Q4 2025.
BeOne Medicines (BEIGF) EBIT (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of EBIT data on file, last reported at $249.9 million in Q1 2026.
- EBIT for Q1 2026 came in at $249.9 million, up 2150.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $685.9 million (up 331.93% YoY), and the FY2025 annual result was $447.1 million, up 178.69% from the prior year.
- EBIT rose to $249.9 million in Q1 2026 per BEIGF's latest filing, from $185.0 million in the prior quarter.
- Over five years, EBIT peaked at $249.9 million in Q1 2026 and troughed at -$468.6 million in Q4 2022.
- A 5-year average of -$168.7 million and a median of -$134.0 million in 2023 frame the typical range for EBIT.
- The sharpest annual moves came in 2022 and 2026: EBIT tumbled 731.76% in 2022, then soared 2150.96% in 2026.
- A 5-year view of EBIT shows it stood at -$468.6 million in 2022, then gained by 18.1% to -$383.8 million in 2023, then soared by 79.31% to -$79.4 million in 2024, then soared by 332.97% to $185.0 million in 2025, then surged by 35.06% to $249.9 million in 2026.
- Business Quant data shows BEIGF's EBIT at $249.9 million in Q1 2026, $185.0 million in Q4 2025, and $163.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -65.83 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 249.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.90 Mn |
| Dec 31, 2025 | 185.04 Mn |
| Sep 30, 2025 | 163.11 Mn |
| Jun 30, 2025 | 87.89 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | -79.43 Mn |
| Sep 30, 2024 | -120.27 Mn |
| Jun 30, 2024 | -107.16 Mn |
| Mar 31, 2024 | -261.35 Mn |
| Dec 31, 2023 | -383.80 Mn |
| Sep 30, 2023 | -133.97 Mn |
| Jun 30, 2023 | -318.72 Mn |
| Mar 31, 2023 | -371.26 Mn |
| Dec 31, 2022 | -468.62 Mn |
| Sep 30, 2022 | -438.36 Mn |
| Jun 30, 2022 | -439.40 Mn |
| Mar 31, 2022 | -443.29 Mn |
| Dec 31, 2021 | 190.56 Mn |
| Sep 30, 2021 | -462.33 Mn |
| Jun 30, 2021 | -474.84 Mn |